WIN-Partners CoTSE:3183 +0.31%63 PEG Ratio is 3.03 as of Jul. 09, 2026, which is 109% above its 10-year median of 1.45. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 48 Medical Distribution companies, WIN-Partners Co ranks worse than 62.5% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for WIN-Partners Co's PEG Ratio or its related term are showing as below:
TSE:3183'
s PEG Ratio Range Over the Past 10 Years
Min: 0.6 Med: 1.45 Max: 7.42
Current: 3.03
During the past 13 years, WIN-Partners Co's highest PEG Ratio was 7.42. The lowest was 0.60. And the median was 1.45.
TSE:3183's PEG Ratio is ranked worse than 62.5% of 48
companies
in the Medical Distribution industry
Industry Median: 1.875
vs TSE:3183: 3.03
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
WIN-Partners Co (TSE:3183) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
WIN-Partners Co PEG Ratio Related Terms
WIN-Partners Co PEG Ratio Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, WIN-Partners Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co PEG Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
WIN-Partners Co (TSE:3183) has a PEG Ratio of 3.03 as of Jul. 09, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on WIN-Partners Co and its competitors. This is 109% above median its historical median of 1.45. Over the past decade, WIN-Partners Co's PEG Ratio has ranged from 0.60 to 7.42. According to the industry distribution chart, WIN-Partners Co ranks #30 out of 48 companies in the Medical Distribution industry, placing it in the top 62.5%.
Is WIN-Partners Co's PEG Ratio too high?
WIN-Partners Co's current PEG Ratio of 3.03 is 109% above median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 7.42. The Medical Distribution industry median PEG Ratio is 1.88. WIN-Partners Co's value of 3.03 is 61.6% above this industry median. Based on the distribution chart, WIN-Partners Co ranks #30 out of 48 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's PEG Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #30 out of 48 companies for PEG Ratio. This places WIN-Partners Co in the lower half of its industry. The industry median PEG Ratio is 1.88. WIN-Partners Co's value of 3.03 is 61.6% above this benchmark. Historically, WIN-Partners Co's own PEG Ratio has ranged from 0.60 to 7.42 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 1.88, WIN-Partners Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Distribution company?
The median PEG Ratio among Medical Distribution companies is 1.88, based on 48 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current PEG Ratio of 3.03 is 61.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median PEG Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current PEG Ratio is 3.03, which is 109% above median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current PEG Ratio is 3.03, which is 109% above median its 10-year median of 1.45 and 61.6% above the Medical Distribution industry median of 1.88. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current PEG Ratio is 3.03 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
PEG Ratio: 3.03 (109% above median its 10-year median of 1.45)
GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
Industry Position: 61.6% above the Medical Distribution median (#30 of 48)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score
Get the complete analysis for TSE:3183
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
